Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Research Site, Scottsdale, Arizona Research Site, Duarte, California Research Site, Orange, California Research Site, Boston, Massachusetts Research Site, St Louis, Missouri Research Site, New York, New York Research Site, Durham, North Carolina Research Site, Cleveland, Ohio Research Site, San Antonio, Texas Research Site, Fairfax, Virginia